This approach was tested for targeting HER2 and IL-13Rα2 in an orthotopic xenogeneic GBM mouse model with the use of intratumoral injections: TanCAR-T cells showed enhanced anti-tumor efficacy and improved animal survival [30]. Here, ERBB2 is linked to glioblastoma.